XML 35 R18.htm IDEA: XBRL DOCUMENT

Note 11 - Stock-based Compensation

6 Months Ended

Jun. 30, 2024

Notes to Financial Statements

Shareholders' Equity and Share-Based Payments [Text Block]

11.

Stock-Based Compensation

Stock-based compensation expense for the three and six months ended June 30, 2024 and 2023 was allocated as follows:

		Three Months Ended June 30,								Six Months Ended June 30,
(in thousands)		2024				2023				2024				2023
Cost of revenues		$	66			$	95			$	118			$	164
Sales and marketing expenses			159				195				289				340
General and administrative expenses			927				704				1,698				1,573
Research and development expenses			126				108				221				178
Total stock-based compensation expense		$	1,278			$	1,102			$	2,326			$	2,255

As of June 30, 2024, the total compensation costs related to unvested awards not yet recognized was $7.8 million and the weighted average period over which it is expected to be recognized is approximately 2.0 years. The Company did not capitalize any stock-based compensation.

Restricted stock unit (“RSU”) activity for the six months ended June 30, 2024 was as follows:

										Market-								Performance-
		Time-Based								Based								Based
		Restricted				Grant Date				Restricted				Grant Date				Restricted				Grant Date
		Stock Units				Fair Value				Stock Units				Fair Value				Stock Units				Fair Value
Balance at December 31, 2023			1,164,996			$	3.28				801,845			$	3.37				-			$	-
Granted			981,540				4.00				-				-				375,895				4.19
Vested			(150,383	)			4.95				-				-				-				-
Forfeited			(41,383	)			3.61				-				-				-				-
Balance at June 30, 2024			1,954,770			$	3.51				801,845			$	3.37				375,895			$	4.19

Unvested shares related to market-based and performance-based vesting conditions are reflected at 100% of their target vesting amount in the table above. Actual vesting could range from zero up to 150% of their target amounts.

Performance-based RSU awards are contingent on the achievement of certain performance metrics. Compensation cost associated with performance-based RSUs are recognized based on the estimated number of shares that the Company ultimately expects will be earned. If the estimated number of shares to be earned is revised in the future, then stock-based compensation expense will be adjusted accordingly.

Stock option activity for the six months ended June 30, 2024 was as follows:

		Number of Options				Weighted-Average Exercise Price				Weighted-Average Remaining Contractual Term				Aggregate Intrinsic Value (in thousands)
Outstanding and exercisable at December 31, 2023			924,067			$	3.37
Exercised			(7,848	)			3.58
Cancelled/Forfeited			(19,266	)			4.46
Outstanding and exercisable at June 30, 2024			896,953			$	3.35				3.00			$	91

The aggregate intrinsic value in the preceding table represents the total pre-tax intrinsic value, based on the Company’s closing stock price of $2.85 as of the last trading day of the reporting period, which would have been received by the option holders had all option holders exercised their options as of that date. The aggregate intrinsic value of options exercised during the six months ended June 30, 2024, was not significant.